Hourglass Capital’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-76,400
Closed -$195K 108
2023
Q1
$195K Buy
76,400
+26,100
+52% +$74.8K 0.07% 96
2022
Q4
$126K Hold
50,300
0.04% 98
2022
Q3
$146K Hold
50,300
0.06% 100
2022
Q2
$227K Sell
50,300
-15,000
-23% -$89.2K 0.08% 97
2022
Q1
$524K Buy
65,300
+5,000
+8% +$44.1K 0.16% 76
2021
Q4
$702K Sell
60,300
-149,700
-71% -$1.79M 0.24% 76
2021
Q3
$2.6M Buy
+210,000
New +$2.37M 0.71% 48

Other funds holding SLGC

Hourglass Capital's SLGC Position: Q2 2023 in Review

Hourglass Capital sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q2 2023, closing a stake of 76,400 shares — an estimated $195K sold.

Hourglass Capital first reported a position in SLGC in Q3 2021 and held it in 7 quarters. The position peaked at $2.6M in Q3 2021. 123 funds tracked by Wall St. Rank hold SLGC as of Q2 2023.

  • Hourglass Capital reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Hourglass Capital sold 76,400 SomaLogic, Inc. Class A Common Stock shares in Q2 2023, an estimated $195K.
  • Hourglass Capital first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 7 quarters.
  • Hourglass Capital's SomaLogic, Inc. Class A Common Stock position peaked at $2.6M in Q3 2021.
  • 123 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q2 2023.

Based on Hourglass Capital's 13F filing for Q2 2023, filed 1 Aug 2023.